FDA Nod for Quest's STRATIFY JCV
Recently, Quest Diagnostics received market authorization for its STRATIFY JCV Antibody ELISA testing service from the US Food and Drug Administration.

Bristol-Myers Squibb Delivers Solid Fourth Quarter Capping a Year Highlighted by New Product Approvals, Continued ...
Bristol-Myers Squibb Company today announced solid financial results for the fourth quarter of 2011. This concludes a year in which the Company received important new product approvals for YERVOY and NULOJIX in both the U.S.

Inlyta (axitinib) Approved For Advanced Kidney Cancer, USA
The US FDA has approved Inlyta (axitinib) for the treatment of advanced renal cell carcinoma, a type of kidney cancer, in patients with whom other drugs have not been effective, the FDA (Food and Drug Administration) announced today. Inlyta is made and marketed by pharmaceutical giant Pfizer Inc. Renal cell carcinoma - also known as renal cell cancer or hypernephroma, is a type of kidney cancer ...